JAMESTOWN
24.2.2021 16:24:06 CET | Business Wire | Press release
Global real estate and investment company Jamestown today announced it has significantly expanded its global presence and now has more than $1 billion in European assets under management with the acquisition of another two buildings in Amsterdam, and a mandate to manage a portfolio of properties across Europe on behalf of one of its institutional investment partners and co-investors, E.ON Pension Trust. This latest news about its European portfolio comes on the heels of Jamestown’s recent purchase of three office buildings in Cologne, Germany, and just over a year after purchasing the iconic Groot Handelsgebouw in Rotterdam, one of the largest mixed-use buildings in the Netherlands, which currently houses more than 450 businesses.
“After entering the European market just over a year ago, Jamestown has grown its platform with $1 billion in assets under management and a knowledgeable real estate team headquartered in Cologne, Germany and offices in Amsterdam, London, and Madrid,” said Jamestown president Michael Phillips. “We continue to see many opportunities for future growth. Our vertically integrated team structure is at the root of our value-add asset management strategy enabling us to create innovative spaces while simultaneously preserving cities’ industrial pasts. As our European footprint expands, we will continue to focus on sustainable, adaptive reuse projects that bring new life to local communities.”
Jamestown’s newly acquired Dutch assets are in Amsterdam’s up-and-coming Schinkel neighborhood and include the historic A-Factorij, previously owned by E.ON Pension Trust and home to one of Jamestown’s European offices, and Helicopterstraat, a property previously owned by Gerose and comprised of four buildings on the adjoining Helicopterstraat, Vliegtuigstraat, and Valschermkade. The properties were acquired in partnership with E.ON Pension Trust and the RAG-Stiftung. E.ON Pension Trust made the decision to include A-Factorij in the co-investment given their belief in the long-term potential of the neighborhood, and that future opportunities in the neighborhood with the newly acquired properties are better acted on as co-investors.
In addition, Jamestown will provide asset management services for a portfolio of properties owned by E.ON Pension Trust in Italy, the Netherlands, Portugal, Spain, and the UK. The properties Jamestown will manage include a mix of shopping centers, office buildings, and mixed-use developments.
“We have known Jamestown for a long time and they have been a great partner to us in the US,” said Udo Schaffer, Vice President, Head of Real Estate, E.ON SE. “Jamestown is one of our preferred global partners given their active approach to asset management and focus on creative and out-of-the-box thinking. After several co-investments with Jamestown in Europe, we now look forward to working with them on the E.ON Pension Trust Separate Account Portfolio.”
A-Factorij (Pilotenstraat 35-45), a 128,177 square foot / 11,908 square meter former bicycle factory was originally built in 1955 and converted into a creative office space in 2002. Jamestown has been involved in management of the property since 2018. Adjacent to A-Factorij is Helicopterstraat, a 67,102 square foot / 6,234 square meter commercial property comprising four interconnected offices and industrial space, with a showroom and gym on the ground floor. The Schinkel district is transforming from industrial and loft offices to a true mixed-use community with a residential focus. The Amsterdam municipality plans to turn the 247-acre neighborhood into a vibrant, innovative, and sustainable district with international allure.
Gerose was represented by Appelhoven Real Estate Advisors in this off-market transaction.
Van Ooijen Accountants & Tax Advisors (Paul van der Aar and Adriaan Daniels) were the legal & tax advisors of the seller, together with HMK Notarissen. Greenberg Traurig represented Jamestown.
“This area of Amsterdam has generated a lot of interest from institutional and private investors from around the world,” said Stijn Uijthoven of Appelhoven Real Estate Advisors. “The properties Jamestown has acquired from Gerose Vastgoed were designed to be flexible and sustainable, and responsive to the changing neighborhood. It was a pleasure to work with Jamestown on this transaction and I look forward to seeing the evolution of the properties and the larger community in the coming years.”
Jamestown has a long-standing commitment to securing a better future for its tenants, residents, visitors, and investors by creating spaces that are sustainable, healthy, and inclusive. In 2020, after achieving its goal to reduce energy and greenhouse gas (GHG) emissions by 20 percent four years ahead of schedule, Jamestown committed to reducing its GHG emissions once again by committing to achieve net zero operational carbon by 2050. Jamestown also joined the ranks of other forward-thinking global organizations and 193 countries, and has adopted the United Nations Sustainable Development Goals into its corporate sustainability strategy.
For high-resolution images of A-Factorij and Helicopterstraat, please click here .
About Jamestown
Jamestown is a design-focused real estate investment and management company with a 37-year track record and a clear mission: to transform spaces into innovation hubs and community centers. Jamestown employs more than 400 people worldwide with headquarters in Atlanta, Georgia, and Cologne, Germany, and offices in Amsterdam, Bogotá, Boston, London, Los Angeles, Madrid, New York, and San Francisco. The company is well-known in the industry for its market discipline. Since its founding in 1983, Jamestown has executed transactions in excess of $35 billion, and as of December 31, 2020, the company has assets under management of $12.1 billion. Current and previous iconic projects include Chelsea Market in New York City, Industry City in Brooklyn, Ponce City Market in Atlanta, Ghirardelli Square in San Francisco, and the Innovation and Design Building in Boston. In addition to its portfolio in key markets throughout the U.S., Jamestown continues to expand its investment footprint to South America and Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005702/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
